Centpropazine

Experimental antidepressant From Wikipedia, the free encyclopedia

Centpropazine (CPZ, CTZ) is an experimental antidepressant of the phenylpiperazine family which was under development for the treatment of major depressive disorder in India but was never marketed.[1][2][3] It is described as having imipramine-like clinical effects, reversing reserpine-induced effects in animals, and potentiating amphetamine-induced effects in animals.[3] The mechanism of action of centpropazine is unknown.[4] The drug reached phase 3 clinical trials prior to the discontinuation of its development.[1] It was first described in the scientific literature by 1980.[3][5]

Other namesCPZ; CTZ
CAS Number
Quick facts Clinical data, Other names ...
Centpropazine
Clinical data
Other namesCPZ; CTZ
Routes of
administration
Oral[1]
Identifiers
  • 1-[4-[2-hydroxy-3-(4-phenylpiperazin-1-yl)propoxy]phenyl]propan-1-one
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC22H28N2O3
Molar mass368.477 g·mol−1
3D model (JSmol)
  • CCC(=O)C1=CC=C(C=C1)OCC(CN2CCN(CC2)C3=CC=CC=C3)O
  • InChI=1S/C22H28N2O3/c1-2-22(26)18-8-10-21(11-9-18)27-17-20(25)16-23-12-14-24(15-13-23)19-6-4-3-5-7-19/h3-11,20,25H,2,12-17H2,1H3
  • Key:ZQPXSRTZFYHSFB-UHFFFAOYSA-N
Close

See also

References

Related Articles

Wikiwand AI